M. Bigorre

Early Sirolimus Therapy Combined With Sclerotherapy for the Management of Extensive Neonatal Cervicofacial Lymphatic Malformations: Clinical and MR-Volumetric Follow-up in a Series of 10 Patients

Antoine Fraissenon, Francis Fortin, Sara Cabet, Fernanda Frade et autres

Objectives: Extensive cervicofacial lymphatic malformations (ECFLM) can be highly challenging, especially due to mass effect on the upper airways. Our goal is to underline the interest of neonatal institution of sirolimus combined with macro-cyst sclerotherapy in such conditions. Methods: Ten neonates with …

fr (code pays fourni par la source)

Higher Doses of Oral Propranolol for Resistant Infantile Haemangiomas

I. Dreyfus, C. Denos, O. Boccara, S. Barbarot et autres

Propranolol at 3 mg/kg/day is considered the gold standard for treating infantile haemangiomas. Nevertheless, the management of propranolol-resistant infantile haemangiomas (PRIH) remains challenging. This national multicentre retrospective observational study includes all PRIHs who received propranolol > 3 mg/kg/day. The study aims to …

fr, jp, re (code pays fourni par la source)

Soft-Tissue Congenital Hemangiomas and Related Complications: A Retrospective Cohort of 14 Cases With Emphasis on Prenatal Diagnosis, Counseling, and Postnatal Management

Francis Fortin, Antoine Fraissenon, An Lesage, Sara Cabet et autres

Objectives: We aimed to describe prenatal imaging findings of superficial congenital hemangiomas (CH), review associated complications, and describe outcomes. Methods: A single-center retrospective cohort study spanning 18 years (2006–2024) reviewed imaging and medical charts of fetuses with soft-tissue masses suggestive of CH …

fr, ca (code pays fourni par la source)

Expanding the Phenotypic Spectrum of SecVAUS : Report of Two Cases

Marion Descos, Paul Kuentz, Christine Labrèze, M. Bigorre et autres

All data underlying the results are available as part of the article and no additional source data are required.

fr (code pays fourni par la source)

Cirugía de los quistes y fístulas de la cara y del cuello

A. Belkhou, M. Bigorre

fr (code pays fourni par la source)

Chirurgia delle cisti e delle fistole della faccia e del collo

A. Belkhou, M. Bigorre

fr (code pays fourni par la source)

Surgical treatment of arteriovenous malformations of the buttock

Claude Laurian, Nikos Paraskevas, M. Bigorre, Claudine Masonni et autres

For symptomatic buttock arteriovenous malformations (AVMs), embolization techniques and surgical resection have been suggested as treatment options. Our aim was to evaluate the feasibility and long-term results after a single surgical resection. Twelve patients had undergone surgical resection without preoperative embolization. Of …

fr (code pays fourni par la source)

Primary cheilorhinoseptoplasty using the Talmant protocol in unilateral complete cleft lip: functional and aesthetic results on nasal correction and comparison with the Tennison–Malek protocol

M.J. Nicol, M. de Boutray, Guillaume Captier, M. Bigorre

fr (code pays fourni par la source)

Infraumbilical raphe: a new congenital anomaly in PELVIS syndrome

Fabian Blanc, D. Bessis, M. Bigorre

International audience

fr (code pays fourni par la source)

Hemangiol in infantile haemangioma: A paediatric post‐marketing surveillance drug study

Floriane Socchi, M. Bigorre, Marion Normandin, Guillaume Captier et autres

AIM: Infantile haemangioma (IH) is the most common benign tumour in children. Since 2014, propranolol has become the first-choice therapy and currently Hemangiol is the only approved drug for complicated haemangioma. This post-marketing study reports the use of Hemangiol for IH in …

fr (code pays fourni par la source)

Prenatal ultrasound diagnosis of cleft palate without cleft lip, the new ultrasound semiology

Jean Michel Faure, E. Mousty, M. Bigorre, Constance Wells et autres

OBJECTIVES: The aim of this study was to define the prenatal ultrasound semiology of cleft palate without cleft lip using 3D visualization of the fetal palate. METHODS: A prospective longitudinal study was performed in our University Hospital Center from 2011 to 2018. …

fr (code pays fourni par la source)

Hemangiol® in infantile haemangioma: A paediatric post-marketing surveillance drug study

Floriane Socchi, M. Bigorre, Marion Normandin, Guillaume Captier et autres

Aim: Infantile haemangioma (IH) is the most common benign tumour in children. Since 2014, propranolol has become the first-choice therapy and currently Hemangiol® is the only approved drug for complicated haemangioma. This post-marketing study reported the use of Hemangiol® for IH in …

fr (code pays fourni par la source)